Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/86242

Documents

In Collections

This item can be found in the following collections:

Schaik, I.N. van; Bril, V.; Geloven, N. van; Hartung, H.P.; Lewis, R.A.; Sobue, G.; ... ; PATH Study Grp (2018)

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Article / Letter to editor
All authors
Schaik, I.N. van; Bril, V.; Geloven, N. van; Hartung, H.P.; Lewis, R.A.; Sobue, G.; Lawo, J.P.; Praus, M.; Mielke, O.; Durn, B.L.; Cornblath, D.R.; Merkies, I.S.J.; PATH Study Grp
Date
2018-01-31
Journal
The Lancet Neurology
Volume
17
Issue
1
Pages
35 - 46
DOI
doi:10.1016/S1474-4422(17)30378-2